Cargando…

Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease

BACKGROUND: Hyperinsulinemia aggravates insulin resistance and cardio-vascular disease. How the insulinotropic glucagon-like peptide-1 receptor agonist liraglutide in a physiologic post-prandial setting may act on pancreatic alpha and beta-cell function in patients with coronary artery disease (CAD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anholm, Christian, Kumarathurai, Preman, Jürs, Anders, Pedersen, Lene Rørholm, Nielsen, Olav Wendelboe, Kristiansen, Ole Peter, Fenger, Mogens, Holst, Jens Juul, Madsbad, Sten, Sajadieh, Ahmad, Haugaard, Steen Bendix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543623/ https://www.ncbi.nlm.nih.gov/pubmed/31164926 http://dx.doi.org/10.1186/s13098-019-0438-6

Ejemplares similares

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study
por: Kumarathurai, Preman, et al.
Publicado: (2016)

Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol
por: Anholm, Christian, et al.
Publicado: (2014)

Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study
por: Kumarathurai, Preman, et al.
Publicado: (2021)

Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial
por: Pedersen, Lene Rørholm, et al.
Publicado: (2019)

Coronary microvascular function, insulin sensitivity and body composition in predicting exercise capacity in overweight patients with coronary artery disease
por: Jürs, Anders, et al.
Publicado: (2015)

Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol
por: Pedersen, Lene Rørholm, et al.
Publicado: (2013)

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function
por: Kielgast, Urd, et al.
Publicado: (2011)

The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial
por: Samkani, Amirsalar, et al.
Publicado: (2018)

Parasympathetic tonus in type 2 diabetes and pre-diabetes and its clinical implications
por: Hadad, Rakin, et al.
Publicado: (2022)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019)

Skeletal muscle structural lipids improve during weight-maintenance after a very low calorie dietary intervention
por: Haugaard, Steen B, et al.
Publicado: (2009)

Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial
por: Thomsen, Mads N., et al.
Publicado: (2022)

Gastric bypass surgery reveals independency of obesity and diabetes melitus type 2
por: Fenger, Mogens, et al.
Publicado: (2016)

Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans
por: Asmar, Meena, et al.
Publicado: (2010)

Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study
por: Carlsson, Elin Rebecka, et al.
Publicado: (2019)

P‐wave indices as predictors of atrial fibrillation
por: Rasmussen, Maria Uggen, et al.
Publicado: (2020)

Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status
por: Carlsson, Elin Rebecka, et al.
Publicado: (2018)

Fractionated free fatty acids and their relation to diabetes status after Roux‐en‐Y gastric bypass: A cohort study
por: Eriksen, Freja, et al.
Publicado: (2021)

Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial
por: Thirumathyam, Roopameera, et al.
Publicado: (2022)

Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial
por: Thomsen, Mads N., et al.
Publicado: (2022)

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study
por: Dejgaard, Thomas Fremming, et al.
Publicado: (2015)

Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet
por: Jensen, Simon Birk Kjær, et al.
Publicado: (2019)

Effects of Carbohydrate Restriction on Body Weight and Glycemic Control in Individuals with Type 2 Diabetes: A Randomized Controlled Trial of Efficacy in Real-Life Settings
por: Weber, Philip, et al.
Publicado: (2022)

Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension
por: Fenger, Mogens, et al.
Publicado: (2011)

Effect of Meal Texture on Postprandial Glucose Excursions and Gut Hormones After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
por: Hedbäck, Nora, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis
por: Pedersen, Julie Steen, et al.
Publicado: (2020)

Coronary flow velocity reserve by echocardiography: feasibility, reproducibility and agreement with PET in overweight and obese patients with stable and revascularized coronary artery disease
por: Olsen, Rasmus Huan, et al.
Publicado: (2016)

Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects
por: Samkani, Amirsalar, et al.
Publicado: (2018)

Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment
por: Jensen, Simon Birk Kjær, et al.
Publicado: (2022)

What is Diabetes Remission?
por: Holst, Jens J., et al.
Publicado: (2021)

SAT032 Circulating Neprilysin Activity Is Increased In Type 2 Diabetes And Fatty Liver Disease, And Reduces Following Bariatric Surgery And Liraglutide Therapy
por: Sampson Kjeldsen, Sasha Alexandra, et al.
Publicado: (2023)

Echocardiographic subtypes of heart failure in consecutive hospitalised patients with dyspnoea
por: Nielsen, Olav Wendelboe, et al.
Publicado: (2019)

Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB
por: Engelbrechtsen, L., et al.
Publicado: (2017)

Long-Term Exposure to Road Traffic Noise and Nitrogen Dioxide and Risk of Heart Failure: A Cohort Study
por: Sørensen, Mette, et al.
Publicado: (2017)

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function
por: Kielgast, Urd, et al.
Publicado: (2011)

Reduction of oxidative stress on DNA and RNA in obese patients after Roux-en-Y gastric bypass surgery—An observational cohort study of changes in urinary markers
por: Carlsson, Elin Rebecka, et al.
Publicado: (2020)

High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease
por: Mouridsen, Mette Rauhe, et al.
Publicado: (2014)

Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials
por: Dejgaard, Thomas F., et al.
Publicado: (2021)

The effect of DPP-4-protected GLP-1 (7–36) on coronary microvascular function in obese adults
por: Nilsson, Malin, et al.
Publicado: (2019)

Effects of a Self-Prepared Carbohydrate-Reduced High-Protein Diet on Cardiovascular Disease Risk Markers in Patients with Type 2 Diabetes
por: Alzahrani, Ahmad H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bpt0ier6h3mc03494sqhm5td48